Mizuho Trust & Banking’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-4,590
Closed -$43K 522
2016
Q3
$43K Buy
4,590
+715
+18% +$6.83K ﹤0.01% 836
2016
Q2
$40K Buy
3,875
+3,420
+752% +$31.3K ﹤0.01% 846
2016
Q1
$4K Sell
455
-4,235
-90% -$37.9K ﹤0.01% 846
2015
Q4
$43K Buy
4,690
+705
+18% +$7.72K ﹤0.01% 775
2015
Q3
$51K Sell
3,985
-3,650
-48% -$45.3K ﹤0.01% 821
2015
Q2
$84K Buy
7,635
+1,295
+20% +$14.3K ﹤0.01% 825
2015
Q1
$72K Buy
+6,340
New +$67.3K ﹤0.01% 849

Other funds holding RDY

Mizuho Trust & Banking's RDY Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of Dr. Reddy's Laboratories (RDY) in Q4 2016, closing a stake of 4,590 shares — an estimated $43K sold.

Mizuho Trust & Banking first reported a position in RDY in Q1 2015 and held it in 7 quarters. The position peaked at $84K in Q2 2015. 164 funds tracked by Wall St. Rank hold RDY as of Q4 2016.

  • Mizuho Trust & Banking reported no remaining Dr. Reddy's Laboratories position as of Q4 2016 after selling out during the quarter.
  • Mizuho Trust & Banking sold 4,590 Dr. Reddy's Laboratories shares in Q4 2016, an estimated $43K.
  • Mizuho Trust & Banking first reported a position in Dr. Reddy's Laboratories in Q1 2015 and held it in 7 quarters.
  • Mizuho Trust & Banking's Dr. Reddy's Laboratories position peaked at $84K in Q2 2015.
  • 164 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.